156 related articles for article (PubMed ID: 31727509)
1. Production of
Friend MT; Mastren T; Parker TG; Vermeulen CE; Brugh M; Birnbaum ER; Nortier FM; Fassbender ME
Appl Radiat Isot; 2020 Feb; 156():108973. PubMed ID: 31727509
[TBL] [Abstract][Full Text] [Related]
2. Production of 230U/226Th for targeted alpha therapy via proton irradiation of 231Pa.
Morgenstern A; Lebeda O; Stursa J; Bruchertseifer F; Capote R; McGinley J; Rasmussen G; Sin M; Zielinska B; Apostolidis C
Anal Chem; 2008 Nov; 80(22):8763-70. PubMed ID: 18925748
[TBL] [Abstract][Full Text] [Related]
3. Cross-sections of the reaction 232Th(p,3n)230Pa for production of 230U for targeted alpha therapy.
Morgenstern A; Apostolidis C; Bruchertseifer F; Capote R; Gouder T; Simonelli F; Sin M; Abbas K
Appl Radiat Isot; 2008 Oct; 66(10):1275-80. PubMed ID: 18374585
[TBL] [Abstract][Full Text] [Related]
4. A simple-rapid method to separate uranium, thorium, and protactinium for U-series age-dating of materials.
Knight AW; Eitrheim ES; Nelson AW; Nelson S; Schultz MK
J Environ Radioact; 2014 Aug; 134():66-74. PubMed ID: 24681438
[TBL] [Abstract][Full Text] [Related]
5. (232)Th(d,4n)(230)Pa cross-section measurements at ARRONAX facility for the production of (230)U.
Duchemin C; Guertin A; Haddad F; Michel N; Métivier V
Nucl Med Biol; 2014 May; 41 Suppl():e19-22. PubMed ID: 24485989
[TBL] [Abstract][Full Text] [Related]
6. An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT).
Baimukhanova A; Engudar G; Marinov G; Kurakina E; Dadakhanov J; Karaivanov D; Yang H; Ramogida CF; Schaffer P; Magomedbekov EP; Filosofov D; Radchenko V
Nucl Med Biol; 2022; 112-113():35-43. PubMed ID: 35797877
[TBL] [Abstract][Full Text] [Related]
7. Separation of Protactinium Employing Sulfur-Based Extraction Chromatographic Resins.
Mastren T; Stein BW; Parker TG; Radchenko V; Copping R; Owens A; Wyant LE; Brugh M; Kozimor SA; Nortier FM; Birnbaum ER; John KD; Fassbender ME
Anal Chem; 2018 Jun; 90(11):7012-7017. PubMed ID: 29757620
[TBL] [Abstract][Full Text] [Related]
8. Production of medical isotopes from a thorium target irradiated by light charged particles up to 70 MeV.
Duchemin C; Guertin A; Haddad F; Michel N; Métivier V
Phys Med Biol; 2015 Feb; 60(3):931-46. PubMed ID: 25574934
[TBL] [Abstract][Full Text] [Related]
9. Large scale accelerator production of
Griswold JR; Medvedev DG; Engle JW; Copping R; Fitzsimmons JM; Radchenko V; Cooley JC; Fassbender ME; Denton DL; Murphy KE; Owens AC; Birnbaum ER; John KD; Nortier FM; Stracener DW; Heilbronn LH; Mausner LF; Mirzadeh S
Appl Radiat Isot; 2016 Dec; 118():366-374. PubMed ID: 27776333
[TBL] [Abstract][Full Text] [Related]
10. Defining Processing Times for Accelerator Produced
Fitzsimmons J; Griswold J; Medvedev D; Cutler CS; Mausner L
Molecules; 2019 Mar; 24(6):. PubMed ID: 30897722
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Separation of Protactinium-230 and Uranium-230 Isotopes from a Proton-Irradiated Thorium Matrix.
Du M; Dyer T; Thakur P
Anal Chem; 2024 Apr; 96(15):5906-5912. PubMed ID: 38560780
[TBL] [Abstract][Full Text] [Related]
12. Exploration of producing Uranium-232 for use as a tracer in uranium fuels.
Rhodes J; Maldonado GI
Appl Radiat Isot; 2022 Aug; 186():110275. PubMed ID: 35605462
[TBL] [Abstract][Full Text] [Related]
13. Application of ion exchange and extraction chromatography to the separation of actinium from proton-irradiated thorium metal for analytical purposes.
Radchenko V; Engle JW; Wilson JJ; Maassen JR; Nortier FM; Taylor WA; Birnbaum ER; Hudston LA; John KD; Fassbender ME
J Chromatogr A; 2015 Feb; 1380():55-63. PubMed ID: 25596759
[TBL] [Abstract][Full Text] [Related]
14. Proton-induced production and radiochemical isolation of
Radchenko V; Engle JW; Medvedev DG; Maassen JM; Naranjo CM; Unc GA; Meyer CAL; Mastren T; Brugh M; Mausner L; Cutler CS; Birnbaum ER; John KD; Nortier FM; Fassbender ME
Nucl Med Biol; 2017 Jul; 50():25-32. PubMed ID: 28432915
[TBL] [Abstract][Full Text] [Related]
15. Separation of 103Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide 103mRh.
Mastren T; Radchenko V; Hopkins PD; Engle JW; Weidner JW; Copping R; Brugh M; Nortier FM; Birnbaum ER; John KD; Fassbender ME
PLoS One; 2017; 12(12):e0190308. PubMed ID: 29272318
[TBL] [Abstract][Full Text] [Related]
16. Thorium chelators for targeted alpha therapy: Rapid chelation of thorium-226.
Ferrier MG; Li Y; Chyan MK; Wong R; Li L; Spreckelmeyer S; Hamlin DK; Mastren T; Fassbender ME; Orvig C; Wilbur DS
J Labelled Comp Radiopharm; 2020 Oct; 63(12):502-516. PubMed ID: 32812275
[TBL] [Abstract][Full Text] [Related]
17. Chromatographic separation of the theranostic radionuclide
Mastren T; Radchenko V; Engle JW; Weidner JW; Owens A; Wyant LE; Copping R; Brugh M; Nortier FM; Birnbaum ER; John KD; Fassbender ME
Anal Chim Acta; 2018 Jan; 998():75-82. PubMed ID: 29153089
[TBL] [Abstract][Full Text] [Related]
18. Relativistic small-core pseudopotentials for actinium, thorium, and protactinium.
Weigand A; Cao X; Hangele T; Dolg M
J Phys Chem A; 2014 Apr; 118(13):2519-30. PubMed ID: 24628327
[TBL] [Abstract][Full Text] [Related]
19. Bulk production and evaluation of high specific activity
Mastren T; Radchenko V; Bach HT; Balkin ER; Birnbaum ER; Brugh M; Engle JW; Gott MD; Guthrie J; Hennkens HM; John KD; Ketring AR; Kuchuk M; Maassen JR; Naranjo CM; Nortier FM; Phelps TE; Jurisson SS; Wilbur DS; Fassbender ME
Nucl Med Biol; 2017 Jun; 49():24-29. PubMed ID: 28288384
[TBL] [Abstract][Full Text] [Related]
20. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part I: purification of decayed thorium-227 on cation exchange columns.
Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2017 Feb; 43(2):225-233. PubMed ID: 27628177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
